Impact of early accelerated dose tissue plasminogen activator on in-hospital patency of the infarcted vessel in patients with acute right ventricular infarction

Heart

Volumn 77, Issue 6, 1997, Pages 512-516

  Giannitsis, Evangelos ^a   Potratz, Juergen ^a   Wiegand, Uwe ^a   Stierle, Ulrich ^a   Djonlagic, Hasib ^a   Sheikhzadeh, Abdolhamid ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

In hospital patency; Right ventricular infarction; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; BLOOD CLOT LYSIS; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART OUTPUT; HEART RIGHT VENTRICLE INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030875113     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.77.6.512     Document Type: Article

References (36)

1. Fibrinolytic Therapy Trialists (FTT) Collaboratory Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343:311-22.
2. Grines CL, De Maria AN. Optimal utilization of thrombolytic therapy for acute myocardial infarction: concepts and controversies. J Am Coll Cardiol 1990;16:223-31.
3. Berger PB, Ryan TJ. Inferior myocardial infarction-high risk subgroups. Circulation 1990;81:401-11.
4. Zehender M, Kasper W, Kauder E, Schönthaler M, Geibel A, Olschewski M, et al. Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. N Engl J Med 1993;328:981-8.
5. Andersen HR, Nielsen D, Lund O, Falk E. Prognostic significance of right ventricular infarction diagnosed by ST elevation in right chest leads V3R to V7R. Int J Cardiol 1989;23:349-56.
6. Shah PK, Maddahi J, Berman DS, Pichler M, Swan HJC. Scintigraphically detected predominant right ventricular dysfunction in acute myocardial infarction: clinical and hemodynamic correlates and implications for therapy and prognosis. J Am Coll Cardiol 1985;6:1264-72.
7. Verani MS, Tortoledo FE, Batty JW, Raizner AE. Effect of coronary artery recanalization on right ventricular function in patients with acute myocardial infarction. J Am Coll Cardiol 1985;5:1029-35.
8. Lew AS, Laramee P, Shah PK, Maddahi J, Peter T, Ganz W. Ratio of ST-segment depression in lead V2 to ST-segment elevation in lead aVF in evolving inferior acute myocardial infarction: an aid to the early recognition of right ventricular ischemia. Am J Cardiol 1986;57: 1047-51.
9. Kinn JW, Ajluni SC, Samyn JG, Bates ER, Grines CL, O'Neill W. Rapid hemodynamic improvement after reperfusion during right ventricular infarction. J Am Coll Cardiol 1995;26:1230-4.
10. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 1987;76:142-54.
11. Bates ER, Califf RM, Stack RS, Aronson L, George BS, Candela RJ, et al. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) Trial: influence of infarct location on arterial patency, left ventricular function and mortality. J Am Coll Cardiol 1989;13:12-8.
12. Ohman EM, Califf RM, Topol EJ, Candela R, Abbottsmith C, Ellis S, et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. Circulation 1990;82:781-91.
13. Prewitt RM, Downes AMT, Gu S, Chan SM, Ducas J. Effects of hydralazin and increased cardiac output on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolism. Chest 1991;99:708-14.
14. Prewitt RM, Gu S, Garber PJ, Ducas J. Marked systemic hypotension depresses coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activator. J Am Coll Cardiol 1992;20: 1626-33.
15. Bates ER, Topol EJ. Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock. J Am Coll Cardiol 1991;18:1077-84.
16. Berger PB, Ruocco NA, Ryan TJ, Jacobs AK, Zaret BL, Wackers FJ, et al. Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the Thrombolysis in Myocardial Infarction II Trial). Am J Cardiol 1993;71:1148-52.
17. Kalan JM, Gertz SD, Kragel AH, Berger PB, Roberts WC, Ryan TJ. Effects of tissue plasminogen activator therapy on the frequency of acute right ventricular myocardial infarction associated with acute left ventricular infarction. Int J Cardiol 1993;38:151-8.
18. Roth A, Miller HI, Kaluski E, Keren G, Shargorodsky B, Krakover R, et al. Early thrombolytic therapy does not enhance the recovery of the right ventricle in patients with acute inferior myocardial infarction and predominant right ventricular involvement. Cardiology 1990;77: 40-9.
19. Schuler G, Hofmann M, Schwart F, Mehmel H, Manthey J, Tillmanns H, et al. Effect of successful thrombolytic therapy on right ventricular function in acute inferior wall myocardial infarction. Am J Cardiol 1984;54:951-7.
20. Zehender M, Kasper W, Kauder E, Geibel A, Schonthaler M, Olschewski M, et al. Eligibility for and benefit of thrombolytic therapy in inferor myocardial infarction: focus on the prognostic importance of right ventricular infarction. J Am Coll Cardiol 1994;24:362-9.
21. Zehender M, Kasper W, Kauder E, Schönthaler M, Olschewski M, Just H. Comparison of diagnostic accuracy, time dependency, and prognostic impact of abnormal Q waves, combined electrocardiographic criteria, and ST segment abnormalities in right ventricular infarction. Br Heart J 1994;72:119-24.
22. Braat SH, Brugada P, De Zwaan C, Coenegracht JM, Wellens HJJ. Value of electrocardiogram in diagnosing right ventricular involvement in patients with an acute inferior wall myocardial infarction. Br Heart J 1983;49: 368-72.
23. Klein HO, Tordjman T, Ninio R, Sareli P, Oren V, Lang R, et al. The early recognition of right ventricular infarction: diagnostic accuracy of the electrocardiographic V4R lead. Circulation 1983;67:558-65.
24. Lopez-Sendon J, Coma-Canella I, Alcasena S, Seoane J, Gamallo C. Electrocardiographic findings in acute right ventricular infarction: sensitivity and specifity of electrocardiographic alterations in right precordial leads V4R, V3R, V1, V2 and V3. J Am Coll Cardiol 1985;6:1273-9.
25. The GUSTO angiographic investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-22.
26. Topol EJ, Califf RM, Vandormael M, Grines CL, George BS, Sanz ML, et al. A randomized trial of late reperfusion therapy for acute myocardial infarction. Circulation 1992; 85;2090-9.
27. Verheugt FWA, Meijer A, Lagrand WK, van Eenige MJ. Reocclusion: the flip side of coronary thrombolysis. J Am Coll Cardiol 1996;27:766-73.
28. Lincoff AM, Topol EJ. Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation 1993;87:1792-805.
29. Meijer A, Verheugt WA, Werter CJPJ, Lie KI, van der Pol JMJ, van Eenige MJ. Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Circulation 1993;87:1524-30.
30. Lopez-Sendon J, Coma-Canella I, Gamallo C. Sensitivity and specifity of hemodynamic criteria in the diagnosis of acute right ventricular infarction. Circulation 1981;64: 515-25.
31. Gruppo Italiano per lo studio della Streptochinasi nell'infarto miocardico (GISSI). Effectiveness of intravenous trombolytic treatment in acute myocardial infarction. Lancet 1986;i:349-60.
32. Kennedy JW, Gensini GG, Timmis GC, Maynard C. Acute myocardial infarction treated with intracoronary streptokinase: a report of the Society for Cardiac Angiography. Am J Cardiol 1985;55:871-7.
33. Braat SH, de Zwaan C, Brugada P, Coenegracht JM, Wellens HJJ. Right ventricular involvement with acute inferior wall myocardial infarction identifies high risk of developing atrioventricular nodal conduction disturbances. Am Heart J 1984;107:1183-7.
34. Berger PB, Ruocco NA, Ryan TJ, Frederick MM, Podrid PJ. Incidence and significance of ventricular tachycardia and fibrillation in the absence of hypotension or heart failure in acute myocardial infarction treated with recombinant tissue-type plasminogen activator: results from the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial. J Am Coll Cardiol 1993;22:1773-9.
35. Gacioch GM, Topol EJ. Sudden paradoxical clinical deterioration during angioplasty of the occluded right coronary artery in acute myocardial infarction. J Am Coll Cardiol 1989;14:1202-9.
36. Abbottsmith CW, Topol EJ, George BS, Stack RS, Kereiakes DJ, Candela RJ, et al. Fate of patients with acute myocardial infarction with patency of the infarctrelated vessel achieved with successful thrombolysis versus rescue angioplasty. J Am Coll Cardiol 1990;16:770-8.